-
Vaccination in patients with a hematologic condition: Challenging the dogmas in vaccination of the immunocompromised
Haggenburg, S., 2025, 342 p.Research output: PhD thesis › Thesis, fully internal
-
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
Campanella, A., Capasso, A., Heltai, S., Taccetti, C., Albi, E., Herishanu, Y., Haggenburg, S., Chatzikonstantinou, T., Doubek, M., Kättström, M., Giannopoulos, K., Simkovic, M., Moreno, C., Massaia, M., Bumbea, H., Alshemmari, S., Ranghetti, P., Perotta, E., Martini, F. & Sant'Antonio, E. & 24 others, , Apr 2024, In: American Journal of Hematology. 99, 4, p. 745-750 6 p.Research output: Contribution to journal › Letter* › Academic › peer-review
-
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications